CHARLOTTESVILLE, Va. — Perrigo Pediatrics — a pediatrician-support program by U.S. infant formula maker Perrigo — and Wakefield Research, released findings Wednesday from a nationwide survey of 500 U.S. pediatricians that explored top concerns and perceptions around safe infant formula feeding practices. According to the survey, pediatricians report that parents are making unsafe infant-feeding choices
DUBLIN — Perrigo announced Tuesday the successful completion of its acquisition of Ranir, a leading global store brand supplier of oral self-care products, for $750 million in cash. This transaction advances Perrigo’s transformation to a consumer-focused, self-care company while enhancing its position as a global leader in consumer self-care solutions. Perrigo chief executive officer and
ALLEGAN, Mich. — While the holidays are synonymous with peace, love and joy for many Americans who celebrate, the holiday season is actually filled with physical and emotional discomfort, according to a new survey commissioned by the distributor of store brand Omeprazole Delayed Release Orally Disintegrating Tablets 20 mg (Omeprazole ODT). The national “Beating the Holiday
SALT LAKE CITY — Private brand expansion has been a major priority for Amazon with several new labels being introduced every year. According to a new report by eCommerce analytics provider One Click Retail, Amazon is now slowing their private brand expansion in favor of introducing a number of Amazon-exclusive brands. Unlike Amazon-owned private labels, these brands
DUBLIN, Ireland — Perrigo Co. has been cleared by the Food and Drug Administration to market over-the-counter guaifenesin and dextromethorphan hydrobromide extended-release tablets 1200 mg/60 mg, an expectorant and cough suppressant. Perrigo said Wednesday that its guaifenesin and dextromethorphan ER tablets are an OTC generic version of Mucinex DM Maximum Strength tablets from Reckitt Benckiser. Plans call
Amazon.com has made an own-brand foray into the over-the-counter health products market. Published reports said Amazon has quietly introduced a line of OTCs under the Basic Care brand, including items provided by Ireland-based store-brand and generic drug maker Perrigo plc, whose Good Sense private-label products already were sold by the e-tailing giant. The first
DUBLIN, Ireland — Perrigo Co. plc has received approval from the Food and Drug Administration for hydromorphone HCl extended-release tablets 32 mg, an opioid pain medication. Perrigo said it expects to launch its hydromorphone product, a generic verison of Exalgo 32-mg ER tablets from Mallinckrodt, by the end of this month. An opioid agonist, Exalgo
DUBLIN, Ireland — Perrigo Co. plc has received approval from the Food and Drug Administration for nystatin and triamcinolone acetonide cream 100,000 units/gram and 1 mg/gram, an antifungal medication. The company said Wednesday that its nystatin and triamcinolone acetonide product is a generic version of Mycolog II Cream from Bristol-Myers Squibb. The branded product was
DUBLIN, Ireland — John Hendrickson, chief executive officer Perrigo Co. plc, plans to retire from the company after just over a year in the CEO role. Perrigo said late Monday that Hendrickson will remain with the company until his replacement is appointed and up to 60 days thereafter to assist with the transition. Plans call
DUBLIN, Ireland — Perrigo Co. plc has begun shipping a store-brand version of Women’s Rogaine, a foam hair regrowth treatment. Perrigo said it’s the first to market with an over-the-counter, private-label version of minoxidil topical aerosol foam 5%. The product is packaged and marketed as a store brand or retailer “own label brand and provides
DUBLIN, Ireland — Perrigo Co. plc has received approval from the Food and Drug Administration for hydrocodone bitartrate and homatropine methylbromide oral solution 5 mg/1.5 mg per 5 ml. Hydrocodone bitartrate and homatropine methylbromide syrup is indicated for the symptomatic relief of cough in adults and children ages 6 and older. A combination medication, the
DUBLIN, Ireland — Perrigo Co. plc is bringing in methamphetamine-blocking capability for pseudoephedrine (PSE) products. On Tuesday, Perrigo said it has entered an exclusive licensing agreement with St. Louis-based Highland Pharmaceuticals for its Tarex meth-blocking technology. The deal also includes the distribution rights of Zephrex-D, the pseudoephedrine nasal decongestant marketed by Highland’s Westport Pharmaceuticals unit.
DUBLIN, Ireland — Perrigo Co. plc plans to acquire Geiss, Destin & Dunn Inc., a U.S. distributor of over-the-counter health care, personal care and consumer products. Financial terms of the deal weren’t disclosed. Perrigo said Wednesday that it expects to finalize the Geiss, Destin & Dunn (GDD) transaction by the end of August. Based in
DUBLIN, Ireland — Perrigo Co. plc has wrapped up the sale of its U.S. vitamins, minerals and supplements (VMS) business to International Vitamin Corp. (IVC). The cash deal, terms of which weren’t disclosed, was announced in late June. The VMS business was part of the Perrigo Nutritionals division, whose core products are store-brand infant formula